Phase 2 Comparison of Weight-Based Doses of Taribavirin Combined With Peginterferon Alfa 2b Versus Ribavirin Combined With Peginterferon Alfa 2b in Therapy-naive Patients With Chronic Hepatitis C Virus Genotype 1 Infection.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Taribavirin (Primary) ; Peginterferon alfa-2a; Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 27 Jul 2012 Biomarkers information updated
- 26 Nov 2009 Results presented at the 60th Annual Meeting of the American Association for the Study of Liver Diseases.
- 03 Nov 2009 Full final 72-week data presented at the American Association for the Study of Liver Disease (ASSLD) 2009.